These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25076161)

  • 1. Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.
    Franquet E; Palmer MR; Gifford AE; Selen DJ; Chen YC; Sedora-Roman N; Joyce RM; Kolodny GM; Moss AC
    Nucl Med Commun; 2014 Oct; 35(10):1026-31. PubMed ID: 25076161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
    Shmidt E; Nehra V; Lowe V; Oxentenko AS
    BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
    Rosen RS; Fayad L; Wahl RL
    J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A; Yoshida K; Umehara I; Shibuya H
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine.
    Soyka JD; Strobel K; Veit-Haibach P; Schaefer NG; Schmid DT; Tschopp A; Hany TF
    J Nucl Med; 2010 Apr; 51(4):507-10. PubMed ID: 20237041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
    Louis E; Ancion G; Colard A; Spote V; Belaiche J; Hustinx R
    J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
    Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
    J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
    Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
    Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
    Peng J; He Y; Xu J; Sheng J; Cai S; Zhang Z
    Colorectal Dis; 2011 Nov; 13(11):e374-8. PubMed ID: 21831098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal physiologic fluorodeoxyglucose activity in the gastrointestinal tract is located within the colonic lumen.
    Wang K; Chen YC; Palmer MR; Tal I; Ahmed A; Moss AC; Kolodny GM
    Nucl Med Commun; 2012 Jun; 33(6):641-7. PubMed ID: 22240934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
    Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake.
    Groshar D; Bernstine H; Stern D; Sosna J; Eligalashvili M; Gurbuz EG; Niv Y; Fraser G
    J Nucl Med; 2010 Jul; 51(7):1009-14. PubMed ID: 20554741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans.
    Parysow O; Mollerach AM; Jager V; Racioppi S; San Roman J; Gerbaudo VH
    Clin Nucl Med; 2007 May; 32(5):351-7. PubMed ID: 17452860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug.
    Ozülker T; Ozülker F; Mert M; Ozpaçaci T
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):1011-7. PubMed ID: 20107796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of physiologic uptake detected with true whole-body 18F-FDG PET/CT in healthy subjects.
    Reinking MF; Osman MM
    J Nucl Med Technol; 2009 Mar; 37(1):31-7. PubMed ID: 19223428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease.
    Shyn PB; Mortele KJ; Britz-Cunningham SH; Friedman S; Odze RD; Burakoff R; Goldberg JE; Erturk M; Silverman SG
    J Nucl Med; 2010 Dec; 51(12):1841-8. PubMed ID: 21078803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental colonic focal lesions detected by FDG PET/CT.
    Gutman F; Alberini JL; Wartski M; Vilain D; Le Stanc E; Sarandi F; Corone C; Tainturier C; Pecking AP
    AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.